Background and Aims: Liver cirrhosis leads to clinically significant portal hypertension.
Transjugular intrahepatic portosystemic shunt (TIPS) has been shown to effectively reduce …

Macrophage migration inhibitory factor (MIF) as well as its more recently described structural
homolog D-dopachrome tautomerase (D-DT), now also termed MIF-2, are atypical cytokines …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused millions of COVID-
19 cases and deaths worldwide. Severity of pulmonary pathologies and poor prognosis …

Immune-mediated liver damage is the driver of disease progression in patients with chronic
hepatitis B virus (HBV) infection. Liver damage is an Ag-independent process caused by …

Background and aim Since hepatocytes produce majority of serum proteins, patients with
cirrhosis display substantial alterations in the serum proteome. The aim of the current study …

Background & Aims Transjugular intrahepatic portosystemic shunt (TIPS) is the most
effective therapy for complications of portal hypertension. However, clinical outcomes …

Macrophage inhibitory factor (MIF) is a multipotent cytokine, involved in the inflammatory
response to infections or injuries. This study investigates the role of MIF in liver fibrosis and …

Background Liver failure (LF) is characterised by a loss of the synthetic and metabolic liver
function and is associated with a high mortality. Large-scale data on recent developments …

Objective To detect expression and phosphorylation level of macrophage migration inhibitor
(MIF) and extracellular-regulated kinases 1 and 2 (ERK1/2) in hepatitis B-induced liver …

The microbiota in individual habitats differ both in relative composition and absolute
abundance. While sequencing approaches determine only the relative abundances of taxa …